These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 30310466)

  • 1. Nicorandil and Long-acting Nitrates: Vasodilator Therapies for the Management of Chronic Stable Angina Pectoris.
    Tarkin JM; Kaski JC
    Eur Cardiol; 2018 Aug; 13(1):23-28. PubMed ID: 30310466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasodilator Therapy: Nitrates and Nicorandil.
    Tarkin JM; Kaski JC
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):367-378. PubMed ID: 27311574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicorandil for angina--an update.
    Drug Ther Bull; 2003 Nov; 41(11):86-8. PubMed ID: 14658416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.
    Frampton J; Buckley MM; Fitton A
    Drugs; 1992 Oct; 44(4):625-55. PubMed ID: 1281076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy.
    Krumenacker M; Roland E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S93-102. PubMed ID: 1282184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of vasospastic angina--role of nicorandil.
    Kaski JC
    Cardiovasc Drugs Ther; 1995 Mar; 9 Suppl 2():221-7. PubMed ID: 7647026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Systematic review on the short-term efficacy and safety of nicorandil for stable angina pectoris in comparison with those of β-blockers, nitrates and calcium antagonists].
    Hanai Y; Mita M; Hishinuma S; Shoji M
    Yakugaku Zasshi; 2010 Nov; 130(11):1549-63. PubMed ID: 21048416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of nitrates, nitrate-like substances, calcium antagonists and beta-adrenergic receptor blockers on peripheral circulation].
    Busse R; Bassenge E
    Herz; 1982 Dec; 7(6):388-405. PubMed ID: 6131027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hemodynamic effects of nicorandil in coronary artery disease.
    Treese N; Erbel R; Meyer J
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S52-6. PubMed ID: 1282176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicorandil: a potassium channel opening drug for treatment of ischemic heart disease.
    Goldschmidt M; Landzberg BR; Frishman WH
    J Clin Pharmacol; 1996 Jul; 36(7):559-72. PubMed ID: 8844437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial actions of nitrates in cardiovascular disease.
    Abrams J
    Am J Cardiol; 1996 May; 77(13):31C-7C. PubMed ID: 8638524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects.
    Markham A; Plosker GL; Goa KL
    Drugs; 2000 Oct; 60(4):955-74. PubMed ID: 11085202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of chronic nitrate therapy in patients with vasospastic angina: multicentre registry study of the Japanese coronary spasm association.
    Takahashi J; Nihei T; Takagi Y; Miyata S; Odaka Y; Tsunoda R; Seki A; Sumiyoshi T; Matsui M; Goto T; Tanabe Y; Sueda S; Momomura S; Yasuda S; Ogawa H; Shimokawa H;
    Eur Heart J; 2015 Jan; 36(4):228-37. PubMed ID: 25189599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary haemodynamics and vasodilatory profile of a potassium channel opener in patients with coronary artery disease.
    Suryapranata H
    Eur Heart J; 1993 Jul; 14 Suppl B():16-21. PubMed ID: 8370366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology and therapeutic effects of nicorandil.
    Kinoshita M; Sakai K
    Cardiovasc Drugs Ther; 1990 Aug; 4(4):1075-88. PubMed ID: 2150592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nicorandil on QT dispersion in patients with stable angina pectoris undergoing elective angioplasty: A triple-blind, randomized, placebo-controlled study.
    Suleimani HF; Eshraghi A; Daloee MH; Hoseini S; Nakhaee N
    Electron Physician; 2017 Aug; 9(8):4934-4941. PubMed ID: 28979725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variant angina and coronary artery spasm: the clinical spectrum, pathophysiology, and management.
    Kusama Y; Kodani E; Nakagomi A; Otsuka T; Atarashi H; Kishida H; Mizuno K
    J Nippon Med Sch; 2011; 78(1):4-12. PubMed ID: 21389642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacology of nitrates].
    Tamargo Menendez J; Delpón E
    Ann Cardiol Angeiol (Paris); 1997; 46(7):380-90. PubMed ID: 9452771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of nicorandil in the treatment of myocardial ischaemia.
    Falase B; Easaw J; Youhana A
    Expert Opin Pharmacother; 2001 May; 2(5):845-56. PubMed ID: 11336627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of Anti-Ischemic and Cardioprotective Effects of Nicorandil in Patients With Stable Angina].
    Rezvanova YA; Adamchik AS
    Kardiologiia; 2015; 55(8):21-5. PubMed ID: 26761967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.